高氧血症对脓毒症患者的影响——一项多中心随机临床试验的事后分析

IF 10.4 2区 医学 Q1 RESPIRATORY SYSTEM
Pulmonology Pub Date : 2025-12-31 Epub Date: 2024-10-24 DOI:10.1016/j.pulmoe.2023.02.005
G Catalisano, M Ippolito, A Blanda, J Meessen, A Giarratano, N Todesco, V Bonato, F Restuccia, J Montomoli, G Fiore, G Grasselli, P Caironi, R Latini, A Cortegiani
{"title":"高氧血症对脓毒症患者的影响——一项多中心随机临床试验的事后分析","authors":"G Catalisano, M Ippolito, A Blanda, J Meessen, A Giarratano, N Todesco, V Bonato, F Restuccia, J Montomoli, G Fiore, G Grasselli, P Caironi, R Latini, A Cortegiani","doi":"10.1016/j.pulmoe.2023.02.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Administration of supplemental oxygen is a life-saving treatment in critically ill patients. Still, optimal dosing remains unclear during sepsis. The aim of this post-hoc analysis was to assess the association between hyperoxemia and 90-day mortality in a large cohort of septic patients.</p><p><strong>Methods: </strong>This is a post-hoc analysis of the Albumin Italian Outcome Sepsis (ALBIOS) randomized controlled trial (RCT). Patients with sepsis who survived the first 48 h since randomization were included and stratified into two groups according to their average PaO<sub>2</sub> levels during the first 48 h (PaO<sub>2 0-48</sub> <sub>h</sub>). The cut-off value was established at 100 mmHg (average PaO<sub>2 0-48</sub>  <i><sub>h</sub></i> >100 mmHg: hyperoxemia group; PaO<sub>2 0-48h</sub>≤100: normoxemia group). The primary outcome was 90-day mortality.</p><p><strong>Results: </strong>1632 patients were included in this analysis (661 patients in the hyperoxemia group, 971 patients in the normoxemia group). Concerning the primary outcome, 344 (35.4%) patients in the hyperoxemia group vs. 236 (35.7%) in the normoxemia group had died within 90 days from randomization (<i>p</i> = 0.909). No association was found after adjusting for confounders (HR 0.87; CI [95%] 0.736-1.028, <i>p</i> = 0.102) or after excluding patients with hypoxemia at enrollment, patients with lung infection or including post-surgical patients only. Conversely, we found an association between lower risk of 90-day mortality and hyperoxemia in the subgroup including patients who had the lung as primary site of infection (HR 0.72; CI [95%] 0.565-0.918). Mortality at 28 days, ICU mortality, incidence of acute kidney injury, use of renal replacement therapy, days to suspension of vasopressor or inotropic agents, and resolution of primary and secondary infections did not differ significantly. Duration of mechanical ventilation and length of stay in ICU were significantly longer in patients with hyperoxemia.</p><p><strong>Conclusions: </strong>In a post-hoc analysis of a RCT enrolling septic patients, hyperoxemia as average PaO<sub>2</sub>>100 mmHg during the first 48 h was not associated with patients' survival.</p>","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":" ","pages":"2416784"},"PeriodicalIF":10.4000,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of hyperoxemia in patients with sepsis - A post-hoc analysis of a multicentre randomized clinical trial.\",\"authors\":\"G Catalisano, M Ippolito, A Blanda, J Meessen, A Giarratano, N Todesco, V Bonato, F Restuccia, J Montomoli, G Fiore, G Grasselli, P Caironi, R Latini, A Cortegiani\",\"doi\":\"10.1016/j.pulmoe.2023.02.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Administration of supplemental oxygen is a life-saving treatment in critically ill patients. Still, optimal dosing remains unclear during sepsis. The aim of this post-hoc analysis was to assess the association between hyperoxemia and 90-day mortality in a large cohort of septic patients.</p><p><strong>Methods: </strong>This is a post-hoc analysis of the Albumin Italian Outcome Sepsis (ALBIOS) randomized controlled trial (RCT). Patients with sepsis who survived the first 48 h since randomization were included and stratified into two groups according to their average PaO<sub>2</sub> levels during the first 48 h (PaO<sub>2 0-48</sub> <sub>h</sub>). The cut-off value was established at 100 mmHg (average PaO<sub>2 0-48</sub>  <i><sub>h</sub></i> >100 mmHg: hyperoxemia group; PaO<sub>2 0-48h</sub>≤100: normoxemia group). The primary outcome was 90-day mortality.</p><p><strong>Results: </strong>1632 patients were included in this analysis (661 patients in the hyperoxemia group, 971 patients in the normoxemia group). Concerning the primary outcome, 344 (35.4%) patients in the hyperoxemia group vs. 236 (35.7%) in the normoxemia group had died within 90 days from randomization (<i>p</i> = 0.909). No association was found after adjusting for confounders (HR 0.87; CI [95%] 0.736-1.028, <i>p</i> = 0.102) or after excluding patients with hypoxemia at enrollment, patients with lung infection or including post-surgical patients only. Conversely, we found an association between lower risk of 90-day mortality and hyperoxemia in the subgroup including patients who had the lung as primary site of infection (HR 0.72; CI [95%] 0.565-0.918). Mortality at 28 days, ICU mortality, incidence of acute kidney injury, use of renal replacement therapy, days to suspension of vasopressor or inotropic agents, and resolution of primary and secondary infections did not differ significantly. Duration of mechanical ventilation and length of stay in ICU were significantly longer in patients with hyperoxemia.</p><p><strong>Conclusions: </strong>In a post-hoc analysis of a RCT enrolling septic patients, hyperoxemia as average PaO<sub>2</sub>>100 mmHg during the first 48 h was not associated with patients' survival.</p>\",\"PeriodicalId\":54237,\"journal\":{\"name\":\"Pulmonology\",\"volume\":\" \",\"pages\":\"2416784\"},\"PeriodicalIF\":10.4000,\"publicationDate\":\"2025-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pulmonology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.pulmoe.2023.02.005\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.pulmoe.2023.02.005","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景:给氧是危重病人的救命手段。然而,败血症期间的最佳剂量仍不清楚。本事后分析的目的是评估大量脓毒症患者高氧血症与90天死亡率之间的关系。方法:这是一项意大利白蛋白结局败血症(ALBIOS)随机对照试验(RCT)的事后分析。纳入随机分组后48小时内存活的脓毒症患者,并根据患者前48小时的平均PaO2水平(PaO2 0-48小时)分为两组,临界值为100 mmHg(平均PaO2 0-48小时>100 mmHg:高氧血症组;PaO2 0 ~ 48h≤100:正常氧血症组)。主要终点为90天死亡率。结果:共纳入1632例患者(高氧血症组661例,低氧血症组971例)。关于主要结局,高氧血症组344例(35.4%)患者在随机分组后的90天内死亡,正常氧血症组236例(35.7%)死亡(p = 0.909)。校正混杂因素后未发现相关性(HR 0.87;CI [95%] 0.736-1.028, p = 0.102)或排除入组时低氧血症患者、肺部感染患者或仅包括术后患者。相反,我们发现在包括以肺为主要感染部位的患者在内的亚组中,90天死亡率风险较低与高氧血症之间存在关联(HR 0.72;Ci[95%] 0.565-0.918)。28天死亡率、ICU死亡率、急性肾损伤发生率、肾脏替代疗法的使用、停用血管加压剂或肌力药物的天数以及原发性和继发性感染的消退没有显著差异。高氧血症患者机械通气时间和ICU住院时间明显延长。结论:在一项纳入脓毒症患者的随机对照试验的事后分析中,前48小时内平均PaO2>100 mmHg的高氧血症与患者的生存无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effects of hyperoxemia in patients with sepsis - A post-hoc analysis of a multicentre randomized clinical trial.

Background: Administration of supplemental oxygen is a life-saving treatment in critically ill patients. Still, optimal dosing remains unclear during sepsis. The aim of this post-hoc analysis was to assess the association between hyperoxemia and 90-day mortality in a large cohort of septic patients.

Methods: This is a post-hoc analysis of the Albumin Italian Outcome Sepsis (ALBIOS) randomized controlled trial (RCT). Patients with sepsis who survived the first 48 h since randomization were included and stratified into two groups according to their average PaO2 levels during the first 48 h (PaO2 0-48 h). The cut-off value was established at 100 mmHg (average PaO2 0-48  h >100 mmHg: hyperoxemia group; PaO2 0-48h≤100: normoxemia group). The primary outcome was 90-day mortality.

Results: 1632 patients were included in this analysis (661 patients in the hyperoxemia group, 971 patients in the normoxemia group). Concerning the primary outcome, 344 (35.4%) patients in the hyperoxemia group vs. 236 (35.7%) in the normoxemia group had died within 90 days from randomization (p = 0.909). No association was found after adjusting for confounders (HR 0.87; CI [95%] 0.736-1.028, p = 0.102) or after excluding patients with hypoxemia at enrollment, patients with lung infection or including post-surgical patients only. Conversely, we found an association between lower risk of 90-day mortality and hyperoxemia in the subgroup including patients who had the lung as primary site of infection (HR 0.72; CI [95%] 0.565-0.918). Mortality at 28 days, ICU mortality, incidence of acute kidney injury, use of renal replacement therapy, days to suspension of vasopressor or inotropic agents, and resolution of primary and secondary infections did not differ significantly. Duration of mechanical ventilation and length of stay in ICU were significantly longer in patients with hyperoxemia.

Conclusions: In a post-hoc analysis of a RCT enrolling septic patients, hyperoxemia as average PaO2>100 mmHg during the first 48 h was not associated with patients' survival.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pulmonology
Pulmonology Medicine-Pulmonary and Respiratory Medicine
CiteScore
14.30
自引率
5.10%
发文量
159
审稿时长
19 days
期刊介绍: Pulmonology (previously Revista Portuguesa de Pneumologia) is the official journal of the Portuguese Society of Pulmonology (Sociedade Portuguesa de Pneumologia/SPP). The journal publishes 6 issues per year and focuses on respiratory system diseases in adults and clinical research. It accepts various types of articles including peer-reviewed original articles, review articles, editorials, and opinion articles. The journal is published in English and is freely accessible through its website, as well as Medline and other databases. It is indexed in Science Citation Index Expanded, Journal of Citation Reports, Index Medicus/MEDLINE, Scopus, and EMBASE/Excerpta Medica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信